{"sent_idx": "114", "frame_idx": "9", "ev": "Day-and-night closed-loop insulin delivery reduced mean glucose concentration by 0\u00b74 mmol/L (0\u00b71\u20130\u00b77, p=0\u00b70226) compared with usual pump therapy (table 2, figure 3).", "icos": [["1", "usual pump therapy", "closed - loop insulin delivery", "mean glucose concentration"]], "sample": "x"}
{"sent_idx": "117", "frame_idx": "13", "ev": "Compared with usual pump therapy, closed-loop insulin delivery reduced the proportion of time with glucose concentration above the target range (ie, >10 mmol/L) by 6\u00b79 percentage points (3\u00b75\u201310\u00b72, p=0\u00b70003), above 13\u00b79 mmol/L by 3\u00b70 percentage points (1\u00b76\u20134\u00b74, p=0\u00b70002) and above 16\u00b77 mmol/L by 1\u00b72 percentage points (0\u00b76\u20131\u00b79, p=0\u00b70009; table 2).", "icos": [["1", "usual pump therapy", "closed - loop insulin delivery", "proportion of time with glucose concentration"]], "sample": "x"}
{"sent_idx": "155", "frame_idx": "31", "ev": "The proportion of time spent with glucose concentration below the target range (ie, 3\u00b79 mmol/L) during usual pump therapy (5\u00b73%, IQR 3\u00b75\u201310\u00b70) was notably higher in our study than that in Thabit and colleagues' study (3\u00b70%, 1\u00b78\u20136\u00b71)13 but still lower than that in a study in adults with a mean baseline HbA1c of 6\u00b77% (mean proportion of time spent with sensor glucose below target range 14% [SD 11]).19 Another study15 assessed the use of closed-loop insulin delivery during night time in pregnant women with type 1 diabetes, using a control algorithm with a lower glucose setpoint to accommodate lower glucose targets (3\u00b75\u20137\u00b78 mmol/L) for this group of patients.", "icos": [["1", "usual pump therapy", "closed - loop insulin delivery", "time spent with glucose concentration"]], "sample": "x"}
{"sent_idx": "13", "frame_idx": "0", "ev": "The proportion of time when sensor glucose concentration was in target range was 10\u00b75 percentage points higher (95% CI 7\u00b76\u201313\u00b74; p<0\u00b70001) during closed-loop delivery compared with usual pump therapy (65\u00b76% [SD 8\u00b71] when participants used usual pump therapy vs 76\u00b72% [6\u00b74] when they used closed-loop).", "icos": [["0.99961144", "usual pump therapy", "usual pump therapy", "proportion of time when sensor glucose concentration"], ["0.99958414", "usual pump therapy", "closed - loop insulin delivery versus sensor - augmented pump therapy", "proportion of time when sensor glucose concentration"], ["0.9995777", "usual pump therapy", "conventional pump therapy", "proportion of time when sensor glucose concentration"], ["0.9995776", "usual pump therapy", "day - and - night closed - loop insulin delivery", "proportion of time when sensor glucose concentration"], ["0.99957603", "usual pump therapy", "Closed - loop delivery", "proportion of time when sensor glucose concentration"]], "sample": "c"}
{"sent_idx": "14", "frame_idx": "1", "ev": "Compared with usual pump therapy, closed-loop delivery also reduced the proportion of time spent in hypoglycaemia: the proportion of time with glucose concentration below 3\u00b75 mmol/L was reduced by 65% (53\u201374, p<0\u00b70001) and below 2\u00b78 mmol/L by 76% (59\u201386, p<0\u00b70001).", "icos": [["0.99958843", "usual pump therapy", "bihormonal ( insulin and glucagon ) closed - loop system", "proportion of time spent in hypoglycaemia"], ["0.9995722", "usual pump therapy", "Closed - loop delivery", "proportion of time spent in hypoglycaemia"], ["0.99957126", "usual pump therapy", "Closed - loop insulin delivery", "proportion of time spent in hypoglycaemia"], ["0.99957126", "usual pump therapy", "closed - loop insulin delivery", "proportion of time spent in hypoglycaemia"], ["0.9995677", "usual pump therapy", "closed - loop insulin delivery versus sensor - augmented pump therapy", "proportion of time spent in hypoglycaemia"]], "sample": "c"}
{"sent_idx": "14", "frame_idx": "2", "ev": "Compared with usual pump therapy, closed-loop delivery also reduced the proportion of time spent in hypoglycaemia: the proportion of time with glucose concentration below 3\u00b75 mmol/L was reduced by 65% (53\u201374, p<0\u00b70001) and below 2\u00b78 mmol/L by 76% (59\u201386, p<0\u00b70001).", "icos": [["0.9995776", "usual pump therapy", "bihormonal ( insulin and glucagon ) closed - loop system", "proportion of time with glucose concentration"], ["0.9995666", "usual pump therapy", "Closed - loop delivery", "proportion of time with glucose concentration"], ["0.9995622", "usual pump therapy", "closed - loop insulin delivery versus sensor - augmented pump therapy", "proportion of time with glucose concentration"], ["0.99956197", "usual pump therapy", "Closed - loop insulin delivery", "proportion of time with glucose concentration"], ["0.99956197", "usual pump therapy", "closed - loop insulin delivery", "proportion of time with glucose concentration"]], "sample": "c"}
{"sent_idx": "30", "frame_idx": "4", "ev": "The proportion of time when sensor glucose concentration was in target range was 10\u00b75 percentage points higher (95% CI 7\u00b76\u201313\u00b74; p<0\u00b70001) during closed-loop delivery compared with usual pump therapy (65\u00b76% [SD 8\u00b71] when participants used usual pump therapy vs 76\u00b72% [6\u00b74] when they used closed-loop).", "icos": [["0.99961144", "usual pump therapy", "usual pump therapy", "proportion of time when sensor glucose concentration"], ["0.99958414", "usual pump therapy", "closed - loop insulin delivery versus sensor - augmented pump therapy", "proportion of time when sensor glucose concentration"], ["0.9995777", "usual pump therapy", "conventional pump therapy", "proportion of time when sensor glucose concentration"], ["0.9995776", "usual pump therapy", "day - and - night closed - loop insulin delivery", "proportion of time when sensor glucose concentration"], ["0.99957603", "usual pump therapy", "Closed - loop delivery", "proportion of time when sensor glucose concentration"]], "sample": "c"}
{"sent_idx": "31", "frame_idx": "5", "ev": "Compared with usual pump therapy, closed-loop delivery also reduced the proportion of time spent in hypoglycaemia: the proportion of time with glucose concentration below 3\u00b75 mmol/L was reduced by 65% (53\u201374, p<0\u00b70001) and below 2\u00b78 mmol/L by 76% (59\u201386, p<0\u00b70001).", "icos": [["0.99958843", "usual pump therapy", "bihormonal ( insulin and glucagon ) closed - loop system", "proportion of time spent in hypoglycaemia"], ["0.9995722", "usual pump therapy", "Closed - loop delivery", "proportion of time spent in hypoglycaemia"], ["0.99957126", "usual pump therapy", "Closed - loop insulin delivery", "proportion of time spent in hypoglycaemia"], ["0.99957126", "usual pump therapy", "closed - loop insulin delivery", "proportion of time spent in hypoglycaemia"], ["0.9995677", "usual pump therapy", "closed - loop insulin delivery versus sensor - augmented pump therapy", "proportion of time spent in hypoglycaemia"]], "sample": "c"}
{"sent_idx": "31", "frame_idx": "6", "ev": "Compared with usual pump therapy, closed-loop delivery also reduced the proportion of time spent in hypoglycaemia: the proportion of time with glucose concentration below 3\u00b75 mmol/L was reduced by 65% (53\u201374, p<0\u00b70001) and below 2\u00b78 mmol/L by 76% (59\u201386, p<0\u00b70001).", "icos": [["0.9995776", "usual pump therapy", "bihormonal ( insulin and glucagon ) closed - loop system", "proportion of time with glucose concentration"], ["0.9995666", "usual pump therapy", "Closed - loop delivery", "proportion of time with glucose concentration"], ["0.9995622", "usual pump therapy", "closed - loop insulin delivery versus sensor - augmented pump therapy", "proportion of time with glucose concentration"], ["0.99956197", "usual pump therapy", "Closed - loop insulin delivery", "proportion of time with glucose concentration"], ["0.99956197", "usual pump therapy", "closed - loop insulin delivery", "proportion of time with glucose concentration"]], "sample": "c"}
{"sent_idx": "111", "frame_idx": "8", "ev": "The primary outcome of the study\u2014the proportion of time during the whole study period when sensor glucose concentration was in the target range (3\u00b79\u201310\u00b70 mmol/L)\u2014was 10\u00b75 percentage points higher (95% CI 7\u00b76\u201313\u00b74; p<0\u00b70001) during the closed-loop period than during the control period (65\u00b76% [SD 8\u00b71] when participants were using usual pump therapy vs 76\u00b72% [6\u00b74] when they used closed-loop; table 2).", "icos": [["0.99960536", "usual pump therapy", "usual pump therapy", "proportion of time during the whole study period when sensor glucose concentration"], ["0.9995908", "usual pump therapy", "conventional pump therapy", "proportion of time during the whole study period when sensor glucose concentration"], ["0.99953747", "usual pump therapy", "conventional insulin pump therapy", "proportion of time during the whole study period when sensor glucose concentration"], ["0.9994937", "usual pump therapy", "sensor - augmented pump therapy", "proportion of time during the whole study period when sensor glucose concentration"], ["0.9994331", "usual pump therapy", "day - and - night closed - loop insulin delivery", "proportion of time during the whole study period when sensor glucose concentration"]], "sample": "c"}
{"sent_idx": "122", "frame_idx": "18", "ev": "Night-time use of closed-loop insulin delivery significantly increased the proportion of time with glucose concentration in target range by 17\u00b72 percentage points (95% CI 12\u00b70\u201322\u00b74, p<0\u00b70001), reduced mean glucose concentration by 0\u00b74 mmol/L (0\u00b71\u20130\u00b78, p=0\u00b70211), and decreased the burden of hypoglycaemia by 89% (80\u201394, p<0\u00b70001) compared with the control period.", "icos": [["0.9996655", "closed - loop insulin delivery", "Closed - loop insulin delivery", "burden of hypoglycaemia"], ["0.9996655", "closed - loop insulin delivery", "closed - loop insulin delivery", "burden of hypoglycaemia"], ["0.99965763", "closed - loop insulin delivery", "closed - loop insulin", "burden of hypoglycaemia"], ["0.9996542", "closed - loop insulin delivery", "Closed - loop delivery", "burden of hypoglycaemia"], ["0.9996495", "closed - loop insulin delivery", "day - and - night closed - loop insulin delivery", "burden of hypoglycaemia"]], "sample": "c"}
{"sent_idx": "122", "frame_idx": "19", "ev": "Night-time use of closed-loop insulin delivery significantly increased the proportion of time with glucose concentration in target range by 17\u00b72 percentage points (95% CI 12\u00b70\u201322\u00b74, p<0\u00b70001), reduced mean glucose concentration by 0\u00b74 mmol/L (0\u00b71\u20130\u00b78, p=0\u00b70211), and decreased the burden of hypoglycaemia by 89% (80\u201394, p<0\u00b70001) compared with the control period.", "icos": [["0.9996426", "closed - loop insulin delivery", "day - and - night closed - loop insulin delivery", "mean glucose concentration"], ["0.9996364", "closed - loop insulin delivery", "Closed - loop insulin delivery", "mean glucose concentration"], ["0.9996364", "closed - loop insulin delivery", "closed - loop insulin delivery", "mean glucose concentration"], ["0.99961424", "closed - loop insulin delivery", "hybrid closed - loop insulin delivery", "mean glucose concentration"], ["0.99960655", "closed - loop insulin delivery", "Closed - loop delivery", "mean glucose concentration"]], "sample": "c"}
{"sent_idx": "122", "frame_idx": "20", "ev": "Night-time use of closed-loop insulin delivery significantly increased the proportion of time with glucose concentration in target range by 17\u00b72 percentage points (95% CI 12\u00b70\u201322\u00b74, p<0\u00b70001), reduced mean glucose concentration by 0\u00b74 mmol/L (0\u00b71\u20130\u00b78, p=0\u00b70211), and decreased the burden of hypoglycaemia by 89% (80\u201394, p<0\u00b70001) compared with the control period.", "icos": [["0.999663", "closed - loop insulin delivery", "Closed - loop insulin delivery", "proportion of time with glucose concentration"], ["0.999663", "closed - loop insulin delivery", "closed - loop insulin delivery", "proportion of time with glucose concentration"], ["0.9996538", "closed - loop insulin delivery", "Closed - loop delivery", "proportion of time with glucose concentration"], ["0.9996513", "closed - loop insulin delivery", "closed - loop insulin", "proportion of time with glucose concentration"], ["0.999645", "closed - loop insulin delivery", "day - and - night closed - loop insulin delivery", "proportion of time with glucose concentration"]], "sample": "c"}
{"sent_idx": "124", "frame_idx": "22", "ev": "Daytime use of closed-loop insulin delivery increased time spent with glucose concentration in the target range by 8\u00b71 percentage points (95% CI 5\u00b73\u201311\u00b70, p<0\u00b70001) and reduced the burden of hypoglycaemia by 61% (14\u201375, p=0\u00b70001).", "icos": [["0.99963", "closed - loop insulin delivery", "closed - loop insulin", "time spent with glucose concentration"], ["0.9996276", "closed - loop insulin delivery", "Closed - loop insulin delivery", "time spent with glucose concentration"], ["0.9996276", "closed - loop insulin delivery", "closed - loop insulin delivery", "time spent with glucose concentration"], ["0.9996076", "closed - loop insulin delivery", "Closed - loop delivery", "time spent with glucose concentration"], ["0.9995161", "closed - loop insulin delivery", "hybrid closed - loop insulin delivery", "time spent with glucose concentration"]], "sample": "c"}
{"sent_idx": "124", "frame_idx": "23", "ev": "Daytime use of closed-loop insulin delivery increased time spent with glucose concentration in the target range by 8\u00b71 percentage points (95% CI 5\u00b73\u201311\u00b70, p<0\u00b70001) and reduced the burden of hypoglycaemia by 61% (14\u201375, p=0\u00b70001).", "icos": [["0.9996376", "closed - loop insulin delivery", "closed - loop insulin", "burden of hypoglycaemia"], ["0.99962175", "closed - loop insulin delivery", "Closed - loop insulin delivery", "burden of hypoglycaemia"], ["0.99962175", "closed - loop insulin delivery", "closed - loop insulin delivery", "burden of hypoglycaemia"], ["0.99960464", "closed - loop insulin delivery", "Closed - loop delivery", "burden of hypoglycaemia"], ["0.9994947", "closed - loop insulin delivery", "hybrid closed - loop insulin delivery", "burden of hypoglycaemia"]], "sample": "c"}
